Efficacy of liposome bupivacaine in transversus abdominis plane blocks for postoperative analgesia: a systematic review and meta-analysis
Authors:
Open Access
- 19 May 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1803767
Abstract
Objective: This meta-analysis evaluates the efficacy of liposomal bupivacaine (LB) versus standard bupivacaine (SB), with or without adjuvants, in transversus abdominis plane (TAP) blocks for postoperative analgesia. Methods: Registered in PROSPERO (CRD420251084761), this meta-analysis screened randomized controlled trials (RCTs) published from 2000 to 2025 in PubMed, the Cochrane Library, Embase, and Wanfang databases. The primary outcome was the cumulative morphine milligram equivalent (MME) within 1 day after surgery. Secondary outcomes included the MME within 2–3 days after surgery, pain scores on postoperative days 1–3, time to first rescue analgesia, time to first flatus passage, time to first ambulation, postoperative nausea and vomiting (PONV), local anesthetic-related adverse events and toxicity, and length of hospital stay. Results: A total of 13 randomized controlled trials (RCTs) ( n = 1,528) were included in this meta-analysis. Compared to standard bupivacaine, liposomal bupivacaine reduced the MME within 1 day after surgery (mean difference (MD): −0.62 mg, 95%CI: −1.13 to −0.11). Liposomal bupivacaine also reduced pain scores on postoperative days 1–3, measured by the numeric rating scale (NRS; day 1: MD −0.65, 95% CI −1.03 to −0.28; day 2: MD −0.40, 95% CI −0.77 to −0.04; day 3: MD −0.30, 95% CI -0.48 to −0.13), prolonged the duration of analgesia (MD 5.39 h, 95% CI 0.06–10.72), and accelerated flatus passage (MD −0.23 day, 95% CI −0.35 to −0.11). No superiority of LB over SB plus adjuvants was observed in postoperative opioid consumption or pain relief. The quality of evidence was rated as low to very low for these outcomes. Conclusion: Liposomal bupivacaine used in TAP blocks can provide only minimal reductions in opioid consumption and pain relief after surgery compared to standard bupivacaine. Given that the quality of evidence was low to very low, large-scale RCTs are required to validate our findings.Keywords
This publication has 32 references indexed in Scilit:
- Recovery quality of transversus abdominis plane block with liposomal bupivacaine after cesarean delivery: A randomized trialJournal of Clinical Anesthesia, 2024
- Surgical transversus abdominis plane block with liposomal bupivacaine at cesarean: a pilot randomized trialAmerican Journal of Obstetrics & Gynecology MFM, 2023
- A randomized-controlled trial comparing liposomal bupivacaine, plain bupivacaine, and the mixture of liposomal bupivacaine and plain bupivacaine in transversus abdominus plane block for postoperative analgesia for open abdominal hysterectomiesCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2021
- Transversus abdominis plane block with liposomal bupivacaine and its effect on opiate use after weight loss surgery: a randomized controlled trialSurgery for Obesity and Related Diseases, 2020
- Efficacy of liposomal bupivacaine in shoulder surgery: a systematic review and meta-analysisJournal of Shoulder and Elbow Surgery, 2019
- The cost-effectiveness of epidural, patient-controlled intravenous opioid analgesia, or transversus abdominis plane infiltration with liposomal bupivacaine for postoperative pain managementJournal of Clinical Anesthesia, 2019
- Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and TechniquesJAMA Surgery, 2017
- The effect of morphine added to bupivacaine in ultrasound guided transversus abdominis plane (TAP) block for postoperative analgesia following lower abdominal cancer surgery, a randomized controlled studyJournal of Clinical Anesthesia, 2017
- Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: A prospective randomized controlled studyGynecologic Oncology, 2015
- Liposomal bupivacaine peripheral nerve block for the management of postoperative pain2015